Sign Up to like & get
recommendations!
0
Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.1085
Abstract: Abstract Background Cabotegravir (CAB) is an integrase inhibitor in phase 3 clinical trials for the treatment and prevention of HIV. CAB undergoes glucuronidation via UGT1A1 with
read more here.
Keywords:
employee;
severe renal;
subjects severe;
cab ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "IEEE Transactions on Neural Systems and Rehabilitation Engineering"
DOI: 10.1109/tnsre.2022.3156661
Abstract: Brain-controlled wheelchairs are one of the most promising applications that can help people gain mobility after their normal interaction pathways have been compromised by neuromuscular diseases. The feasibility of using brain signals to control wheelchairs…
read more here.
Keywords:
subjects severe;
controlled wheelchairs;
severe spinal;
brain ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "mBio"
DOI: 10.1128/mbio.02940-20
Abstract: With the ongoing pandemic, it is critical to understand how natural immunity against SARS-CoV-2 and COVID-19 develops. We have identified that subjects with more severe COVID-19 disease mount a more robust and neutralizing antibody response…
read more here.
Keywords:
response;
antibody response;
subjects severe;
sars cov ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "International Journal of Approximate Reasoning"
DOI: 10.21474/ijar01/6322
Abstract: Athulya Rajendran 1 , Muhammed Ashraf K 2 , Vidya PS 3 and Dinesh Roy D 4 . 1. Department of Zoology, SreeNarayana College, Cherthala688582, Kerala. 2. Associate Professor, Department of Biochemistry, Govt. Medical College,…
read more here.
Keywords:
dna damage;
kerala;
subjects severe;
zoology ... See more keywords